womens-health
(17)
Aparna Divaraniya Turned a Two-Day Science Sprint Into an Eight-Year Company
The scientist who avoided business classes built Oova by treating entrepreneurship like research: assemble the right people, measure what matters, and let the evidence sharpen the idea.
Denali Dahl Turned a Class Assignment Into a Company Built for the Hard Part
She never planned to run a business. Then a Duke project refused to remain a project, and Denali Dahl learned to translate laboratory precision into the stubborn work of building Kalia Health.
Holly Rockweiler Built a Company Around the Problem Everyone Else Called a Niche
She left a comfortable research career to put the patient back in the room. Twelve years, dozens of patents and one pivotal trial later, Holly Rockweiler's method is still disarmingly simple: listen first, then build.
Bruno Van Tuykom Is Building for the Patient the Market Forgot
An electrical engineer learned to see access as a systems problem. Now he and co-founder Amy Fan are turning an unfashionable constraint - serving people commonly ignored by digital care - into Twentyeight Health's operating design.
Anu Sharma Is Building the Care Company the System Forgot to Design
She spent two decades learning why healthcare resists change. With Millie, Anu Sharma is turning that education into clinics, software and partnerships that can move together.
Kate Condliffe
Kate Condliffe is the co-founder and CEO of Diana Health, a network of women's health practices that partners with hospitals to rebuild their maternity and OB/GYN programs around holistic, team-based care. She launched the company in 2020 out of AlleyCorp's healthcare incubator after two decades scaling high-value care models, including roles as COO of the Clinton Health Access Initiative and COO of the birth-center network Baby+Co. Under her leadership, Diana Health has grown to nine locations across Tennessee, Florida, and Texas, cares for more than 80,000 women annually, and has raised roughly $101 million to date, including a $55 million Series C in 2025.
Aagya Mathur
Aagya Mathur is the co-founder and CEO of Aavia, a Brooklyn-based hormone health company whose app helps people with ovaries understand how their cycle shapes their energy, mood, sleep and focus. A University of Virginia neuroscientist turned MIT Sloan MBA and ex-Deloitte consultant, she co-built Aavia out of an MIT bootcamp into a top-charting wellness app that has reached hundreds of thousands of users on organic growth alone, with backers ranging from MIT delta v to a $9.7M+ funding base.
Hasti Nazem
Hasti Nazem is the Co-CEO and Head of Product and Education at Kindra, a New York-based, science-backed women's health brand building estrogen-free solutions for menopause, vaginal health and intimate care. With roughly a decade at the intersection of life sciences, consumer brand-building and wellness, she co-leads the company alongside Afshan Dosani, grounding products in 160+ clinical studies and patent-pending peptide technology. She came to the work through a winding path: a family of physicians, a pre-med start, a detour into finance before the 2008 crash, and a return to school that led her to build wellness companies focused on sleep and, later, women's health.
Carine Carmy
Carine Carmy is the co-founder and CEO of Origin, a women's health company that has turned pelvic floor and whole-body physical therapy into insurance-covered care available in person across seven states and virtually in all 50. A former go-to-market leader at Amino and Shapeways, she built Origin out of her own decade-long struggle to find treatment, and in January 2026 raised a Series B to scale the model and an AI clinical product, Athena, trained on 39 million patient interactions.
Emilė Radytė
Emilė Radytė is a Harvard- and Oxford-trained neuroscientist and the co-founder and CEO of Samphire Neuroscience, a London-based neurotech company building drug-free, hormone-free wearable devices for menstrual health. Her flagship product, Nettle, is a head-worn device using non-invasive transcranial direct current stimulation (tDCS) to target the neurological drivers of menstrual pain and mood symptoms. Named to the Forbes 30 Under 30 Healthcare list in 2024, she came up through emergency medicine at Harvard and a PhD in psychiatry and engineering at Oxford, and reframes conditions like PMS and PMDD as questions of brain circuitry rather than hormones alone.
Evan Sussman
Evan Sussman is the co-founder and CEO of Granata Bio, a Boston-based biopharma company expanding access to fertility care by in-licensing IVF medications proven abroad and bringing them through U.S. clinical development and commercialization. A former fertility business unit head at EMD Serono, he built Granata to be revenue-positive early through a fee-for-service model, then raised a $14M Series A led by GV (Google Ventures), extended it, acquired ovarian-aging biotech Oviva Therapeutics, and struck a strategic investment and co-development deal with Gedeon Richter.
Monica Molenaar
Monica Molenaar is the co-founder and co-CEO of Alloy Health, a direct-to-consumer digital health company she launched in 2020 with former Marie Claire editor-in-chief Anne Fulenwider to bring credible, science-backed menopause care to women. A Stanford MBA and serial entrepreneur, Molenaar first built Seed + Mill, the artisanal tahini and halva business in New York's Chelsea Market, before turning to women's health. Alloy has raised $21.3 million in total funding, including a $16 million Series A in November 2024, and serves more than 70,000 customers. Molenaar and Fulenwider were named to Inc. Magazine's 2026 Female Founders 500.
Marissa Fayer
Marissa Fayer is a 25-year medtech executive who runs DeepLook Medical, an AI diagnostics company that helps radiologists spot breast cancer earlier in women with dense breast tissue, which she took from concept through FDA clearance into global commercialization. She is also the founder of HERhealthEQ, a nonprofit that has reached over 128,000 women across 12 countries by deploying medical devices for cancers, maternal health, and cardiovascular disease. A partner at women's-health fund Goddess Gaia Ventures and author of the forthcoming book 'Undervalued to Unavoidable,' she argues women's health is not a charitable cause but economic infrastructure that has been systematically underestimated.
Joanna Strober
Joanna Strober is the co-founder and CEO of Midi Health, the first menopause startup to achieve unicorn status, raising $100M in Series D funding in February 2026 at a $1B+ valuation. A former Bessemer Venture Partners general partner and Sterling Stamos managing director turned entrepreneur, she built Midi Health after her own year-long struggle to get a perimenopause diagnosis in her late 40s. Midi now serves 230,000+ patients across all 50 states through a network of 500+ clinicians, with care covered by approximately 80% of PPOs. Named to TIME100 Health 2025, CNBC Changemakers 2025, and Forbes 50 Over 50 2023, Strober is also a published author (Getting to 50/50) and a former founder of Kurbo Health, the first digital therapeutic for childhood obesity, which she sold to WW.
Neda Razavi
Neda Razavi is the CEO and Chairwoman of the Board at iSono Health, a South San Francisco medtech company building the world's first wearable, automated, portable FDA-cleared 3D breast ultrasound system. With 25 years of experience launching 65 products across six global platforms and generating over $9 billion in cumulative revenue at companies including Abbott, Roche, Medtronic, and Natera, Razavi joined iSono Health as an early investor and advisor before taking the helm in November 2023 to lead commercialization of the ATUSA system — a 2-minute, hands-free breast imaging device that pairs robotics, AI, and cloud analytics to make early breast cancer detection accessible to OB/GYNs and primary care providers without requiring a trained sonographer.
Victor Vanbremeersch
Victor Vanbremeersch is a French-born entrepreneur and venture scout operating at the intersection of AI, healthcare, and women's sleep health. As CEO and Co-Founder of Moona Health - an AI-powered CBT-I sleep therapy platform backed by Andreessen Horowitz - and simultaneously a Scout for a16z, he occupies a rare dual role: building a company while sourcing the next generation of founders. Moona Health has raised $3.7M, launched clinical partnerships, and is quietly reshaping how insomnia is diagnosed and treated for women.
Anarghya Vardhana
Anarghya Vardhana is a venture partner at Maveron, the consumer-only VC firm co-founded by Howard Schultz, where she has spent nearly a decade backing iconic consumer brands in health, wellness, and social tech. A Stanford grad who published a math theorem at 17, she moved from Sandia National Labs nuclear research to Google international ops to the boardrooms of startups like Co-Star, Bend Health, and Alife. Forbes named her a 30 Under 30 in VC and their First Diversity Champion across the entire class. Simultaneously serving as Investor in Residence at Vanta, she is one of the few investors who credibly bridges deep technical rigor with consumer intuition - and who also runs trail marathons and dances Bharatanatyam.